Hydrozid  

Brentwood,  TN 
United States
http://bdsccompany.com
  • Booth: 752

Hydrozid is a Danish-designed, FDA-cleared device for the in-office treatment of over 17 types of benign skin lesions. Hydrozid provides clinicians with a powerful, easy-to-use, off-the-shelf system offering superior accuracy & limited side effects. Disposable as normal waste, Hydrozid has a 3 year shelf life.

Brands: Hydrozid


 Show Specials

  • (Apr 04, 2024)
    The Internal Medicine Meeting 2024 price for Hydrozid is $275, originally priced at $399.

 Press Releases

  • FOR IMMEDIATE RELEASE
    BIBAWO Medical – a Danish Specialty Medical Device Company –
    Names BDSC as Master Distributor for Hydrozid in the USA
    Hydrozid is a Danish-designed, FDA-cleared cryosurgery device for the in-office treatment
    of over 17 types of benign skin lesions. Hydrozid provides clinicians with a powerful,
    easy-to-use, off-the-shelf system offering superior accuracy & limited side effects.
    Brentwood, Tennessee, March 14, 2024, BDSC Company, headquartered in the United States, is a
    leading global provider of healthcare supplies. Their mission is bringing the most innovative products
    to both domestic and international markets creating maximum opportunities.
    BDSC is pleased to announce that they have been named as the United States Master Distributor for
    Hydrozid, a next generation cryosurgery device manufactured by BIBAWO Medical. Hydrozid is a
    completely portable liquid nitrogen alternative device that is cleared by the FDA for treatment of many
    types of benign & pre-malignant skin lesions.
    “We are excited to partner with BDSC to bring Hydrozid to health care professionals in the United
    States across various medical specialties,” said Christian Kjerulf-Jensen, CEO of BIBAWO.
    Hydrozid serves as the ideal back up cryosurgery device to busy dermatologists, as well as a first line
    solution for providers in Primary Care, Podiatry, Pediatrics, and Urology. It also features a three year
    shelf life and ease of use advantages compared to other devices. The first cryosurgery device to use
    Norflurane as it’s single cryogen gas, Hydrozid is recyclable and does not contain CFCs or chlorine.
    As the US Master Distributor, BSDC has exclusive rights to promote Hydrozid and will be selecting
    partners to promote to clinicians, healthcare systems, group purchasing organizations, and other
    healthcare entities. BDSC will work through its distribution channels to ensure outstanding provider
    education on product and disease state.
    BDSC has developed both global and domestic relationships directly with manufacturers to bring new
    and innovative products to market. They eliminate unnecessary costs to the supply chain while
    innovating the provider’s business of medicine.
    The majority of BDSC products are developed and manufactured in the USA, ensuring they meet
    stringent quality standards like ISO, FDA, cGMP, and CE mark guidelines. With a dedicated team of
    sales, technical, and customer service professionals, BDSC is committed to delivering the highest
    level of service and support to our valued customers.
    BDSC Company is a US-based, global healthcare supply company committed to bringing clinical
    innovation and financial impact into the healthcare and retail markets domestically and abroad.
    For complete information, visit: https://www.bdsccompany.com/
    If you’d like to be a distribution partner, please reach out at 866-698-3131.

 Products

  • Hydrozid
    The newest advancement in portable cryosurgery to improve patient experience and improve a practice's bottom line....

  • Hydrozid is a Danish-designed, FDA-cleared device for the in-office treatment of over 17 types of benign skin lesions. Hydrozid provides clinicians with a powerful, easy-to-use, off-the-shelf system offering superior accuracy & limited side effects. Disposable as normal waste, Hydrozid has a 3 year shelf life.